Publications:

Favorable immune checkpoint inhibitor outcome of patients with melanoma and NSCLC harboring FAT1 mutations.

Npj Precision Oncology

Zhang, Wenjing W; Tang, Yunfeng Y; Guo, Yuxian Y; Kong, Yujia Y; Shi, Fuyan F; Sheng, Chao C; Wang, Suzhen S; Wang, Qinghua Q

Publication Date: 2022-06-23

Variant appearance in text: FAT1: L3014L

PubMed Link: 35739249

Variant Present in the following documents:

• 41698_2022_292_MOESM1_ESM.xlsx, sheet 1

View BVdb publication page

Patient-derived xenografts and organoids model therapy response in prostate cancer.

Nature Communications

Karkampouna, Sofia S; La Manna, Federico F; Benjak, Andrej A; Kiener, Mirjam M; De Menna, Marta M; Zoni, Eugenio E; Grosjean, Joël J; Klima, Irena I; Garofoli, Andrea A; Bolis, Marco M; Vallerga, Arianna A; Theurillat, Jean-Philippe JP; De Filippo, Maria R MR; Genitsch, Vera V; Keller, David D; Booij, Tijmen H TH; Stirnimann, Christian U CU; Eng, Kenneth K; Sboner, Andrea A; Ng, Charlotte K Y CKY; Piscuoglio, Salvatore S; Gray, Peter C PC; Spahn, Martin M; Rubin, Mark A MA; Thalmann, George N GN; Kruithof-de Julio, Marianna M

Publication Date: 2021-02-18

Variant appearance in text: FAT1: Leu3014Leu

PubMed Link: 33602919

Variant Present in the following documents:

• 41467_2021_21300_MOESM5_ESM.xlsx, sheet 3

View BVdb publication page